Abstract
Our previous study identified two alternate non-coding upstream exons (A and B) in the human reduced folate carrier (hRFC) gene, each controlled by a separate promoter. Each minimal promoter was regulated by unique cis -elements and transcription factors, including stimulating protein (Sp) 1 and Sp3 and the basic leucine zipper family of proteins, suggesting opportunities for cell- and tissue-specific regulation. Studies were performed to explore the expression patterns of hRFC in human tissues and cell lines. Levels of hRFC transcripts were measured on a multi-tissue mRNA array from 76 human tissues and tumour cell lines and on a multi-tissue Northern blot of representative tissues, each probed with full-length hRFC cDNA. hRFC transcripts were ubiquitously expressed, with the highest level in placenta and the lowest level in skeletal muscle. By rapid amplification of cDNA 5'-ends assay from nine tissues and two cell lines, hRFC transcripts containing both A and B 5'-untranslated regions (UTRs) were identified. However, five additional 5'-UTRs (designated A1, A2, C, D and E) were detected, mapping over 35 kb upstream from the hRFC translation start site. The 5'-UTRs were characterized by multiple transcription start sites and/or alternative splice forms. At least 18 unique hRFC transcripts were detected. A novel promoter was localized to a 453 bp fragment, including 442 upstream of exon C and 11 bp of exon C. A 346 bp repressor flanked the 3'-end of this promoter. Our results suggest an intricate regulation of hRFC gene expression involving multiple promoters and non-coding exons. Moreover, they provide a transcriptional framework for understanding the role of hRFC in the pathophysiology of folate deficiency and antifolate drug selectivity.
Full Text
The Full Text of this article is available as a PDF (470.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berry R. J., Li Z., Erickson J. D., Li S., Moore C. A., Wang H., Mulinare J., Zhao P., Wong L. Y., Gindler J. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999 Nov 11;341(20):1485–1490. doi: 10.1056/NEJM199911113412001. [DOI] [PubMed] [Google Scholar]
- Butterworth C. E., Jr, Bendich A. Folic acid and the prevention of birth defects. Annu Rev Nutr. 1996;16:73–97. doi: 10.1146/annurev.nu.16.070196.000445. [DOI] [PubMed] [Google Scholar]
- Chancy C. D., Kekuda R., Huang W., Prasad P. D., Kuhnel J. M., Sirotnak F. M., Roon P., Ganapathy V., Smith S. B. Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium. J Biol Chem. 2000 Jul 7;275(27):20676–20684. doi: 10.1074/jbc.M002328200. [DOI] [PubMed] [Google Scholar]
- Chen L., Qi H., Korenberg J., Garrow T. A., Choi Y. J., Shane B. Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene. J Biol Chem. 1996 May 31;271(22):13077–13087. doi: 10.1074/jbc.271.22.13077. [DOI] [PubMed] [Google Scholar]
- Chiao J. H., Roy K., Tolner B., Yang C. H., Sirotnak F. M. RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem. 1997 Apr 25;272(17):11165–11170. doi: 10.1074/jbc.272.17.11165. [DOI] [PubMed] [Google Scholar]
- Choi S. W., Mason J. B. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000 Feb;130(2):129–132. doi: 10.1093/jn/130.2.129. [DOI] [PubMed] [Google Scholar]
- Elwood P. C., Nachmanoff K., Saikawa Y., Page S. T., Pacheco P., Roberts S., Chung K. N. The divergent 5' termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure. Biochemistry. 1997 Feb 11;36(6):1467–1478. doi: 10.1021/bi962070h. [DOI] [PubMed] [Google Scholar]
- Fiaschi T., Chiarugi P., Veggi D., Raugei G., Ramponi G. The inhibitory effect of the 5' untranslated region of muscle acylphosphatase mRNA on protein expression is relieved during cell differentiation. FEBS Lett. 2000 May 4;473(1):42–46. doi: 10.1016/s0014-5793(00)01496-4. [DOI] [PubMed] [Google Scholar]
- Filley C. M., Kleinschmidt-DeMasters B. K. Toxic leukoencephalopathy. N Engl J Med. 2001 Aug 9;345(6):425–432. doi: 10.1056/NEJM200108093450606. [DOI] [PubMed] [Google Scholar]
- Fournier B., Truong-Bolduc Q. C., Zhang X., Hooper D. C. A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J Bacteriol. 2001 Apr;183(7):2367–2371. doi: 10.1128/JB.183.7.2367-2371.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glynn S. A., Albanes D. Folate and cancer: a review of the literature. Nutr Cancer. 1994;22(2):101–119. doi: 10.1080/01635589409514336. [DOI] [PubMed] [Google Scholar]
- Goldman I. D., Matherly L. H. The cellular pharmacology of methotrexate. Pharmacol Ther. 1985;28(1):77–102. doi: 10.1016/0163-7258(85)90083-x. [DOI] [PubMed] [Google Scholar]
- Gong M., Cowan K. H., Gudas J., Moscow J. A. Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1). Gene. 1999 Jun 11;233(1-2):21–31. doi: 10.1016/s0378-1119(99)00166-3. [DOI] [PubMed] [Google Scholar]
- Gong M., Yess J., Connolly T., Ivy S. P., Ohnuma T., Cowan K. H., Moscow J. A. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line. Blood. 1997 Apr 1;89(7):2494–2499. [PubMed] [Google Scholar]
- Gorlick R., Goker E., Trippett T., Steinherz P., Elisseyeff Y., Mazumdar M., Flintoff W. F., Bertino J. R. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood. 1997 Feb 1;89(3):1013–1018. [PubMed] [Google Scholar]
- Guo W., Healey J. H., Meyers P. A., Ladanyi M., Huvos A. G., Bertino J. R., Gorlick R. Mechanisms of methotrexate resistance in osteosarcoma. Clin Cancer Res. 1999 Mar;5(3):621–627. [PubMed] [Google Scholar]
- Hernández-Díaz S., Werler M. M., Walker A. M., Mitchell A. A. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000 Nov 30;343(22):1608–1614. doi: 10.1056/NEJM200011303432204. [DOI] [PubMed] [Google Scholar]
- Honein M. A., Paulozzi L. J., Mathews T. J., Erickson J. D., Wong L. Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001 Jun 20;285(23):2981–2986. doi: 10.1001/jama.285.23.2981. [DOI] [PubMed] [Google Scholar]
- Jansen G., Mauritz R., Drori S., Sprecher H., Kathmann I., Bunni M., Priest D. G., Noordhuis P., Schornagel J. H., Pinedo H. M. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem. 1998 Nov 13;273(46):30189–30198. doi: 10.1074/jbc.273.46.30189. [DOI] [PubMed] [Google Scholar]
- Jansen G., Westerhof G. R., Jarmuszewski M. J., Kathmann I., Rijksen G., Schornagel J. H. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem. 1990 Oct 25;265(30):18272–18277. [PubMed] [Google Scholar]
- Kim Y. I. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999 Feb;10(2):66–88. doi: 10.1016/s0955-2863(98)00074-6. [DOI] [PubMed] [Google Scholar]
- Kocarek T. A., Zangar R. C., Novak R. F. Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch Biochem Biophys. 2000 Apr 1;376(1):180–190. doi: 10.1006/abbi.2000.1704. [DOI] [PubMed] [Google Scholar]
- Matherly L. H., Czajkowski C. A., Angeles S. M. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res. 1991 Jul 1;51(13):3420–3426. [PubMed] [Google Scholar]
- Matherly L. H. Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol. 2001;67:131–162. doi: 10.1016/s0079-6603(01)67027-2. [DOI] [PubMed] [Google Scholar]
- Matherly L. H., Taub J. W. Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. Leuk Lymphoma. 1996 May;21(5-6):359–368. doi: 10.3109/10428199609093433. [DOI] [PubMed] [Google Scholar]
- Morshed K. M., Ross D. M., McMartin K. E. Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells. J Nutr. 1997 Jun;127(6):1137–1147. doi: 10.1093/jn/127.6.1137. [DOI] [PubMed] [Google Scholar]
- Nguyen T. T., Dyer D. L., Dunning D. D., Rubin S. A., Grant K. E., Said H. M. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology. 1997 Mar;112(3):783–791. doi: 10.1053/gast.1997.v112.pm9041240. [DOI] [PubMed] [Google Scholar]
- Prasad P. D., Ramamoorthy S., Leibach F. H., Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun. 1995 Jan 17;206(2):681–687. doi: 10.1006/bbrc.1995.1096. [DOI] [PubMed] [Google Scholar]
- Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995 Dec 11;23(23):4878–4884. doi: 10.1093/nar/23.23.4878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Refsum H., Ueland P. M., Nygård O., Vollset S. E. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62. doi: 10.1146/annurev.med.49.1.31. [DOI] [PubMed] [Google Scholar]
- Roberts S. J., Chung K. N., Nachmanoff K., Elwood P. C. Tissue-specific promoters of the alpha human folate receptor gene yield transcripts with divergent 5' leader sequences and different translational efficiencies. Biochem J. 1997 Sep 1;326(Pt 2):439–447. doi: 10.1042/bj3260439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roy K., Mitsugi K., Sirotnak F. M. Organization and alternate splicing of the murine folylpolyglutamate synthetase gene. Different splice variants in L1210 cells encode mitochondrial or cytosolic forms of the enzyme. J Biol Chem. 1996 Sep 27;271(39):23820–23827. doi: 10.1074/jbc.271.39.23820. [DOI] [PubMed] [Google Scholar]
- Sadlish H., Murray R. C., Williams F. M., Flintoff W. F. Mutations in the reduced-folate carrier affect protein localization and stability. Biochem J. 2000 Mar 1;346(Pt 2):509–518. [PMC free article] [PubMed] [Google Scholar]
- Schuetz J. D., Matherly L. H., Westin E. H., Goldman I. D. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line. J Biol Chem. 1988 Jul 15;263(20):9840–9847. [PubMed] [Google Scholar]
- Serot J. M., Christmann D., Dubost T., Béne M. C., Faure G. C. CSF-folate levels are decreased in late-onset AD patients. J Neural Transm (Vienna) 2001;108(1):93–99. doi: 10.1007/s007020170100. [DOI] [PubMed] [Google Scholar]
- Sirotnak F. M., Moccio D. M., Kelleher L. E., Goutas L. J. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res. 1981 Nov;41(11 Pt 1):4447–4452. [PubMed] [Google Scholar]
- Sirotnak F. M., Moccio D. M., Yang C. H. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system. J Biol Chem. 1984 Nov 10;259(21):13139–13144. [PubMed] [Google Scholar]
- Sirotnak F. M. Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications for improved therapy of human cancer. Cancer Res. 1985 Sep;45(9):3992–4000. [PubMed] [Google Scholar]
- Sirotnak F. M., Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr. 1999;19:91–122. doi: 10.1146/annurev.nutr.19.1.91. [DOI] [PubMed] [Google Scholar]
- Tolner B., Roy K., Sirotnak F. M. Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5' end heterogeneity. Gene. 1998 May 12;211(2):331–341. doi: 10.1016/s0378-1119(98)00123-1. [DOI] [PubMed] [Google Scholar]
- Turner F. B., Andreassi 2nd J. L., Ferguson J., Titus S., Tse A., Taylor S. M., Moran R. G. Tissue-specific expression of functional isoforms of mouse folypoly-gamma-glutamae synthetase: a basis for targeting folate antimetabolites. Cancer Res. 1999 Dec 15;59(24):6074–6079. [PubMed] [Google Scholar]
- Turner F. B., Taylor S. M., Moran R. G. Expression patterns of the multiple transcripts from the folylpolyglutamate synthetase gene in human leukemias and normal differentiated tissues. J Biol Chem. 2000 Nov 17;275(46):35960–35968. doi: 10.1074/jbc.M005228200. [DOI] [PubMed] [Google Scholar]
- Wang Y., Zhao R., Russell R. G., Goldman I. D. Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochim Biophys Acta. 2001 Jul 2;1513(1):49–54. doi: 10.1016/s0005-2736(01)00340-6. [DOI] [PubMed] [Google Scholar]
- Whetstine J. R., Matherly L. H. The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. Basis for tissue-specific gene expression. J Biol Chem. 2000 Nov 14;276(9):6350–6358. doi: 10.1074/jbc.M008074200. [DOI] [PubMed] [Google Scholar]
- Williams F. M., Flintoff W. F. Structural organization of the human reduced folate carrier gene: evidence for 5' heterogeneity in lymphoblast mRNA. Somat Cell Mol Genet. 1998 May;24(3):143–156. doi: 10.1023/b:scam.0000007117.50428.63. [DOI] [PubMed] [Google Scholar]
- Wong S. C., McQuade R., Proefke S. A., Bhushan A., Matherly L. H. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity. Biochem Pharmacol. 1997 Jan 24;53(2):199–206. doi: 10.1016/s0006-2952(96)00710-1. [DOI] [PubMed] [Google Scholar]
- Wong S. C., Proefke S. A., Bhushan A., Matherly L. H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem. 1995 Jul 21;270(29):17468–17475. doi: 10.1074/jbc.270.29.17468. [DOI] [PubMed] [Google Scholar]
- Wong S. C., Zhang L., Proefke S. A., Hukku B., Matherly L. H. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells. Biochem Pharmacol. 1998 Apr 1;55(7):1135–1138. doi: 10.1016/s0006-2952(97)00639-4. [DOI] [PubMed] [Google Scholar]
- Yang C. H., Sirotnak F. M., Mines L. S. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling. J Biol Chem. 1988 Jul 15;263(20):9703–9709. [PubMed] [Google Scholar]
- Zhang L., Taub J. W., Williamson M., Wong S. C., Hukku B., Pullen J., Ravindranath Y., Matherly L. H. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin Cancer Res. 1998 Sep;4(9):2169–2177. [PubMed] [Google Scholar]
- Zhang L., Wong S. C., Matherly L. H. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem J. 1998 Jun 15;332(Pt 3):773–780. doi: 10.1042/bj3320773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao R., Russell R. G., Wang Y., Liu L., Gao F., Kneitz B., Edelmann W., Goldman I. D. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem. 2001 Mar 30;276(13):10224–10228. doi: 10.1074/jbc.c000905200. [DOI] [PubMed] [Google Scholar]